1. Home
  2. SGBX vs PMN Comparison

SGBX vs PMN Comparison

Compare SGBX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Safe & Green Holdings Corp.

SGBX

Safe & Green Holdings Corp.

HOLD

Current Price

$1.96

Market Cap

20.0M

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$8.48

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGBX
PMN
Founded
2007
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.0M
23.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SGBX
PMN
Price
$1.96
$8.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
1.1M
22.9K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,382,896.00
N/A
Revenue This Year
$1,628.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.81
$6.27
52 Week High
$122.88
$39.75

Technical Indicators

Market Signals
Indicator
SGBX
PMN
Relative Strength Index (RSI) 39.20 66.18
Support Level $1.83 $6.62
Resistance Level $2.22 $8.59
Average True Range (ATR) 0.22 0.58
MACD -0.03 -0.24
Stochastic Oscillator 15.22 69.76

Price Performance

Historical Comparison
SGBX
PMN

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: